Magen Scientific Founder Named Chairman of Dermatology at MGH

* Reuters is not responsible for the content in this press release.

Tue Jan 15, 2008 9:00am EST 

WALTHAM, Mass.--(Business Wire)--Magen BioSciences, Inc., announced today the appointment of David
E. Fisher, M.D., Ph.D. as the new Chairman of Dermatology at
Massachusetts General Hospital (MGH), effective January 1, 2008. Dr.
Fisher is a co-founder of Magen Biosciences, Inc. a privately held
dermatology specialty pharmaceutical company. In addition to this
position, Dr. Fisher will also be the Director of the Melanoma Program
in Medical Oncology and the Director of the Cutaneous Biology Research
Center all at MGH.

   "We are delighted by David's appointment and look forward to
continuing to work closely with him in our research and development
programs at Magen," said Brian M. Gallagher, Ph.D., President and CEO
of Magen. Dr. Fisher is also Chairman of Magen's Scientific Advisory
Board and a member of the company's Board of Directors.

   About Magen BioSciences

   Magen BioSciences was founded in 2006 by an outstanding group of
scientists and investors to build a science-based dermatology company.
The company is a research and development stage enterprise that
acquires and develops novel and proprietary technologies and is
headquartered in Waltham, Massachusetts.

   For more information, visit www.magenbiosciences.com

Mersana Therapeutics, Inc.
Pete Leone, 617-498-0020
Chief Operating Officer
or
Media:
KMorrisPR
Kathryn Morris, 845-635-9828
kathryn@kmorrispr.com

Copyright Business Wire 2008
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.